Aug 13, 2025 02:23
VRCA - Verrica Pharmaceuticals Inc. Common Stock
Day | 1m | 10m | 60m | PreMarket | Market | AfterHours | Gap |
---|---|---|---|---|---|---|---|
4.1 -0.08 (-1.95%) | --- | --- | 0.0 (0.0%) | -0.1 (-2.38%) | 0.04 (0.99%) | 0.0 (0.0%) | 0.0 (0.0%) |
Verrica Pharmaceuticals Inc is a dermatology therapeutics company engaged in the development and commercialization of novel treatments that provide a meaningful benefit for people living with skin diseases. Its product candidate, VP-102, is developed for the treatment of molluscum contagiosum, or molluscum, a contagious and pediatric viral skin disease, and common warts.
Category:
PHARMACEUTICAL PREPARATIONS
Market Period:
AfterHours
Earnings & Ratios
- Basic EPS:
- 0.02
- Diluted EPS:
- 0.02
- Basic P/E:
- 201.0
- Diluted P/E:
- 201.0
- RSI(14) 1m:
- 0.0
- VWAP:
- 4.02
- RVol:
- 0.0984
Events
Period | Kind | Movement | Occurred At |
---|
Related News
Oct 24, 2024 11:00
Aug 14, 2024 11:45
Jul 01, 2024 11:30
May 15, 2024 11:30
May 14, 2024 13:01
May 13, 2024 12:40
May 13, 2024 11:30
May 09, 2024 12:10
May 09, 2024 11:30